Skip to content

sudation therapy for joint pain

EFFECT OF SANKAR SWEDAN IN SANDHIVATA WITH SPECIAL REFERENCE TO SNIGDHA PINDA SWEDAN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012636
Enrollment
40
Registered
2018-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Symtoms of Sandhivat (Pain, swalling in joint etc.)

Interventions

None listed

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients representing sign and symptomsofâ??Sandhigatavataâ?? (OA of knee joint). 2)Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: a) Diabetes mellitus. b) Pulmonary T.B. c) Cardiac problem d) Severe Anemia e) Hemophilia f) Deformities of Joints g) Renal failure h) Ankylosingspondylitis

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Snigdha PindaSwedaand Nadi Sweda in Sandhigata vataTimepoint: six weeks

Secondary

MeasureTime frame
1.To assess the analgesic, anti-inflammatory action of Snigdha PindaSweda and Nadi Sweda. 2.To compare of Snigdha Pinda Sweda and Nadi Sweda. 3.To analyze the association between obesity, chronicity of disease and relief in the signs and symptoms Timepoint: six weeks

Countries

India

Contacts

Public ContactSandip Baheti

CCRAS

sandiprbaheti@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026